Women continue to be disproportionally affected by HIV around the world, but particularly in sub-Saharan Africa, where three in four new HIV infections are among young girls. But what can be done in these communities where access to once-a-day pill preventatives are non-existent?
Dr. Phil Santangelo is professor in Coulter Department of Biomedical Engineering. His research is focused on treating diseases like HIV through RNA-based therapies, and he’s getting close to delivering an HIV preventative for women.
